Published in Hepatitis Weekly, April 19th, 2004
According to a study from Japan, "recurrence of hepatitis C virus after liver transplantation is common and cholestatic hepatitis occurs in approximately 10% of the patients and leads to accelerated graft failure and death.
"A 47-year-old man underwent living donor liver transplantation for hepatitis C-related liver cirrhosis. Pre-emptive antiviral therapy was started using interferon-alpha2b (6 MU x 3 per week) and ribavirin (600mg per day) 2 months after living donor liver transplantation," wrote J. Kaneko and colleagues, University of Tokyo, Graduate School of Medicine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.